Eelco de Koning
Eelco de Koning
Unknown affiliation
Verified email at
Cited by
Cited by
Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes
CJM Loomans, EJP de Koning, FJT Staal, MB Rookmaaker, C Verseyden, ...
Diabetes 53 (1), 195-199, 2004
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
JAP Da Silva, JWG Jacobs, JR Kirwan, M Boers, KG Saag, LBS Inęs, ...
Annals of the rheumatic diseases 65 (3), 285-293, 2006
A single-cell transcriptome atlas of the human pancreas
MJ Muraro, G Dharmadhikari, D Grün, N Groen, T Dielen, E Jansen, ...
Cell systems 3 (4), 385-394. e3, 2016
A single-cell transcriptome atlas of the human pancreas
MJ Muraro, G Dharmadhikari, D Grün, N Groen, T Dielen, E Jansen, ...
Cell systems 3 (4), 385-394. e3, 2016
Unlimited in vitro expansion of adult bi‐potent pancreas progenitors through the Lgr5/R‐spondin axis
M Huch, P Bonfanti, SF Boj, T Sato, CJM Loomans, M Van De Wetering, ...
The EMBO journal 32 (20), 2708-2721, 2013
Metabolic and additional vascular effects of thiazolidinediones
FMAC Martens, FLJ Visseren, J Lemay, EJP de Koning, TJ Rabelink
Drugs 62 (10), 1463-1480, 2002
De novo prediction of stem cell identity using single-cell transcriptome data
D Grün, MJ Muraro, JC Boisset, K Wiebrands, A Lyubimova, ...
Cell stem cell 19 (2), 266-277, 2016
Postprandial recruitment of neutrophils may contribute to endothelial dysfunction
A Van Oostrom, TP Sijmonsma, C Verseyden, E Jansen, EJP De Koning, ...
Journal of lipid research 44 (3), 576-583, 2003
Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response
ML Bots, J Westerink, TJ Rabelink, EJP de Koning
European heart journal 26 (4), 363-368, 2005
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
A Moran, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
The Lancet 381 (9881), 1905-1915, 2013
Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?
DR Witte, J Westerink, EJ de Koning, Y van der Graaf, DE Grobbee, ...
Journal of the American College of Cardiology 45 (12), 1987-1993, 2005
Thiazolidinediones and blood lipids in type 2 diabetes
JPH Van Wijk, EJP De Koning, EP Martens, TJ Rabelink
Arteriosclerosis, thrombosis, and vascular biology 23 (10), 1744-1749, 2003
Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population
EJP De Koning, NL Bodkin, BC Hansen, A Clark
Diabetologia 36 (5), 378-384, 1993
The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation
M Cnop, SJ Hughes, M Igoillo-Esteve, MB Hoppa, F Sayyed, ...
Diabetologia 53 (2), 321-330, 2010
Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor
N Steeghs, H Gelderblom, J Op't Roodt, O Christensen, P Rajagopalan, ...
Clinical Cancer Research 14 (11), 3470-3476, 2008
Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate
R Van Etten, E de Koning, M Verhaar, C Gaillard, T Rabelink
Diabetologia 45 (7), 1004-1010, 2002
Intravital microscopy through an abdominal imaging window reveals a pre-micrometastasis stage during liver metastasis
L Ritsma, EJA Steller, E Beerling, CJM Loomans, A Zomer, C Gerlach, ...
Science translational medicine 4 (158), 158ra145-158ra145, 2012
Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial
JPH van Wijk, EJP de Koning, MC Cabezas, J op't Roodt, J Joven, ...
Annals of internal medicine 143 (5), 337-346, 2005
Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients
JPH van Wijk, EJP de Koning, MC Cabezas, J Joven, J op’t Roodt, ...
Journal of the American College of Cardiology 47 (6), 1117-1123, 2006
Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function?
A Clark, LC Jones, E de Koning, BC Hansen, DR Matthews
Diabetes 50 (suppl 1), S169, 2001
The system can't perform the operation now. Try again later.
Articles 1–20